COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 2015: Articles 20141-20150  | Next

EXPLORING THE HEALTHY BEHAVIORS OF NIGERIANS DURING THE COVID-19 PANDEMIC.
Eyisi, I. M.
10.1101/2020.11.25.20235457 — Posted: 2020-11-28
Covid-19 vaccination intentions among Canadian parents of 9-12 year old children: results from the All Our Families longitudinal cohort
Hetherington, E., Edwards, S., MacDonal, S., Racine, N., Madigan, S., McDonald, S., Tough, S.
10.1101/2020.11.24.20237834 — Posted: 2020-11-28
Positive rates predict death rates of Covid-19 locally and worldwide 13 days ahead
Mimkes, J., Janssen, R.
10.1101/2020.11.24.20237842 — Posted: 2020-11-28
Effect of RBD mutation (Y453F) in spike glycoprotein of SARS-CoV-2 on neutralizing antibody affinity
Hayashi, T., Yaegashi, N., Konishi, I.
10.1101/2020.11.27.401893 — Posted: 2020-11-28
Unheeded SARS-CoV-2 protein? Look deep into negative-sense RNA
Bartas, M., Volna, A., Brazda, V., Cerven, J., Pecinka, P.
10.1101/2020.11.27.400788 — Posted: 2020-11-27
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y., Lim, J. M., Kunasegaran, K., Tan, L., Dutertre, C.-A., Shankar, N., Lim, J. M., Sun, L. J., Zahari, M., Tun, Z. M., Kumar, V., Lim, B. L., Lim, S. H., Chia, A., Tan, Y.-J., Tambyah, P. A., Kalimuddin, S., Lye, D. C., Low, J. G., Wang, L.-F., Wan, W. Y., Hsu, L. Y., Bertoletti, A., Tam, C. C.
10.1101/2020.11.25.399139 — Posted: 2020-11-27
A Novel Cell Therapy for COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)
Sivapalan, R., Liu, J., Chakraborty, K., Arthofer, E., Choudhry, M., Barie, P. S., Barouch, D. H., Henley, T.
10.1101/2020.11.26.400390 — Posted: 2020-11-27
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
Tan, E. H., Sena, A. G., Prats-Uribe, A., You, S. C., Ahmed, W.-U.-R., Kostka, K., Reich, C., Duvall, S. L., Lynch, K. E., Matheny, M. E., Duarte-Salles, T., Bertolin, S. F., Hripcsak, G., Natarajan, K., Falconer, T., Spotnitz, M., Ostropolets, A., Blacketer, C., Alshammari, T. M., Alghoul, H., Alser, O., Lane, J. C. E., Dawoud, D. M., Shah, K., Yang, Y., Zhang, L., Areia, C., Golozar, A., Recalde, M., Casajust, P., Jonnagaddala, J., Subbian, V., Vizcaya, D., Lai, L. Y., Nyberg, F., Morales, D. R., Posada, J. D., Shah, N. H., Gong, M., Vivekanantham, A., Abend, A., Minty, E. P., Suchard, M. A., Rijnbeek, P., Ryan, P. B., Prieto-Alhambra, D.
10.1101/2020.11.24.20236802 — Posted: 2020-11-27
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Tellapragada, C., Giske, C.
10.1101/2020.11.24.20237263 — Posted: 2020-11-27
Clonal hematopoiesis is associated with risk of severe Covid-19
Bolton, K. L., Koh, Y., Foote, M. B., Im, H., Jee, J., Sun, C. H., Safonov, A., Ptashkin, R., Moon, J. H., Lee, J. Y., Jun, J., Kang, C. K., Song, K.-H., Choe, P. G., Park, W. B., Oh, M.-d., Kim, H. B., Song, H., Kim, S., Patel, M., Derkach, A., Gedvilaite, E., Tkachuk, K. A., Braunstein, L. Z., Gao, T., Papaemmanuil, E., Babady, E., Pessin, M. S., Kamoj, M., Diaz, L. A., Ladanyi, M., Rauh, M. J., Nataranjan, P., Machiela, M. J., Awadalla, P., Joseph, V., Offit, K., Norton, L., Berger, M., Levine, R. L., Kim, E. S., Kim, N. J., Zehir, A.
10.1101/2020.11.25.20233163 — Posted: 2020-11-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).